Relevant literature has reported that SLC1A5 was the most important transporter to absorb exogenous glutamine in various cells (including breast cancer, NSCLC, prostate cancer, etc.), and regulated tumor growth by controlling the cellular entry of glutamine (Hassanein et al., 2013; van Geldermalsen et al., 2016). The gene discussed is SLC1A5; the disease is breast cancer.